In the recent research, B. bifidum was markedly enriched in the patients who positively responded to the programmed cell death protein 1 (PD-1) blockade, and studies demonstrated that oral gavage of B. bifidum inhibited colon tumor growth in mice through stimulating CD8+ T cells (Lee et al., 2021). The gene discussed is PDCD1; the disease is colonic neoplasm.